Latest news with #GLOBEnewswire
Yahoo
6 days ago
- Business
- Yahoo
Winterberry Group Research Unveils How Marketers Can Improve the Effectiveness Of $1.12 Trillion of Global Media Spend
Anticipates Continuous Adoption of Creative Intelligence Solutions in Next 24-36 Months NEW YORK, June 04, 2025 (GLOBE NEWSWIRE) -- Creative, labeled as 'non-working' media, is responsible for driving 40-70% of an advertising campaign's performance, yet it has been deprioritized and undervalued. Global advertising spend is projected to reach $1.12 trillion by 2026, so investment in creative and content is expected to surpass $140 billion. Winterberry Group, a strategic growth consultancy, today released the findings of a new report that details how to collapse the artificial siloes of 'working' and 'non-working' media and achieve marketing effectiveness with media, audience and creative intelligence. The report defines creative intelligence as the ability to collect, structure and analyze creative decisions against performance data to continuously optimize assets for effectiveness and engagement. 'It is time to overhaul outdated thinking that the billions spent on creative production is non-working,' said Bruce Biegel, senior managing partner of Winterberry Group. 'To truly unlock the full potential of modern marketing effectiveness with greater financial discipline, media, audience and creative data have to converge into a full-funnel, personalized and measurable experience at scale.' Brands and agencies can connect every stage of the creative and campaign process to outcomes. Creative intelligence empowers smarter briefings, pre-flight analysis, real-time activation and optimization as well as creative lifetime value (Creative LTV). With the pace of AI advancements and budgets under pressure, Winterberry predicts creative intelligence will be widely adopted by leading marketers in the next 24-36 months. Starting in channels with the most accessible creative data – social, email and mobile messaging, and then expand into programmatic digital formats such as display, video, audio, and connected TV (CTV). Other key findings from the report include: Nearly half of marketers (49%) still equate 'creative intelligence' with ideation alone, rather than recognizing it as a system for measurement and optimization. Nearly all marketers (99%) view measuring creative LTV as important – with 72% calling it very important. However, only 54% say their organization measures creative LTV very effectively. Creative intelligence is most impactful for understanding brand awareness (41%) and performance outcomes (38%). Creative quality is universally valued as the most important metric for understanding creative intelligence followed by brand lift by both brands (49%) and agencies (38%). Brands then are more interested in measuring conversions (33%), while agencies lean into audience relevance (31%) and engagement (28%). Overall, brands and agencies expect creative intelligence to be led by marketing strategy and operations (but agencies favor external advisory roles more than brands). Brands prioritize agencies for executional support in the evolving creative intelligence ecosystem, while agencies see themselves having more of a focus on technology and strategic integration. 'Intelligent creative isn't an emerging trend, it's the new standard,' said Laura Desmond, CEO of Smartly. 'With audience data in place, AI accelerating, and content demands at an all-time high, brands that harness creative intelligence are turning what was once marketing guesswork into a performance engine. The shift isn't coming, it's already here, and it's redefining how we drive growth with speed, precision, and impact.' 'Winterberry Group's research powerfully validates what we see every day: for too long, creative has been under-leveraged as a driver of marketing effectiveness,' said Wesley ter Haar, Chief AI and Revenue Officer at Monks. 'At Monks, we're focused on building the AI-powered connective tissue that unifies creative, media and audience data, enabling brands to drive measurable and scalable marketing effectiveness everywhere they show up.' 'Creative Intelligence isn't a theory—it's a system,' said Rob Rakowitz, head of marketing at VidMob. 'What makes this whitepaper so valuable is its attention to the mechanics: the inputs, outputs and feedback loops that turn creative into a measurable asset across the entire marketing lifecycle.' 'This valuable research aligns with over two decades of Analytic Partners' ROI Genome findings: Creative is the #2 driver of marketing effectiveness—right after spend,' said Nancy Smith, President and CEO of Analytic Partners. 'Advertisers must incorporate creative within their optimization and measurement programs to maximize commercial impact.' For this research report, Winterberry Group surveyed over 200 senior brand marketing and agencies executives, data, analytics and technology thought leaders across the United States and United Kingdom, conducting in-depth interviews with over 50 industry experts and influencers from customers and users of creative intelligence solutions. This is the first research report in the Winterberry Group series on creative intelligence – 'Demystifying Creative Intelligence: Enhancing Marketing Effectiveness at the Intersection of Media, Audience and Creative.' This report was made possible with the support of IAA North America, Analytic Partners, VidMob, Monks, APR and ContinuumGlobal. The full research report is available for download: About Winterberry Group Winterberry Group is a growth consultancy specializing in the intersecting disciplines of marketing, advertising, technology, data and analytics. We collaborate with stakeholders across those ecosystems—agencies, service providers, technology developers, brands, publishers and investor groups—leveraging deep industry expertise to build actionable strategies that spur growth and drive the creation of real and lasting stakeholder value. Learn more at Media ContactLacy TaltonEvergreen & Oak on behalf of Winterberry Grouplacy@ 252.467.5220 Ilisia ShukeWinterberry Group ishuke@ in to access your portfolio
Yahoo
20-05-2025
- Business
- Yahoo
Global Interventional Treatment Materials Market Trends, Growth Drivers and Future Outlook
Interventional Treatment Materials Market Outlook 2025-2034 Luton, Bedfordshire, United Kingdom, May 20, 2025 (GLOBE NEWSWIRE) -- Introduction The global interventional treatment materials market encompasses the medical devices and materials used in minimally invasive therapeutic procedures. These include essential tools such as catheters, stents, and guidewires, which enable doctors to perform interventions inside the body without open surgery. Over the past decade, there has been a marked shift in healthcare towards minimally invasive interventions due to their benefits in reducing patient trauma, shortening recovery times, and improving outcomes. This trend has fueled growth in the interventional materials market. In 2024, the global market size is estimated around $10.5 billion, and it is on track to expand steadily at a mid-single-digit annual growth rate. By 2034, the market is projected to reach approximately $18 billion, reflecting robust demand and continuous innovation in this field. This report provides a comprehensive analysis of the market's current state, recent developments, key players, and segment-wise insights (by product type, application, end user, technology, and distribution channel), along with forecasts through 2034. Get a Sample PDF Brochure: Market Overview The interventional treatment materials market is experiencing strong growth driven by a confluence of demographic and technological factors. An aging global population and the rising prevalence of chronic diseases are key growth drivers. As conditions like cardiovascular disease, diabetes, and cancer become more common, the need for effective, less invasive treatment options grows. Interventional procedures – such as angioplasty for heart disease or embolization for cancer – often rely on specialized catheters, guidewires, and stents, directly boosting demand for these materials. Additionally, ongoing technological advancements in medical devices are propelling the market forward. Innovations in material science (e.g. more flexible, biocompatible alloys and polymers) have led to next-generation products like drug-eluting stents, bioresorbable stents, and coated balloons that improve patient outcomes. The push toward minimally invasive surgery across medical disciplines has made these interventional tools indispensable in modern treatment protocols. Key Market Drivers and Trends Rising Chronic Disease Prevalence: The increasing incidence of cardiovascular diseases, cancers, and other chronic conditions worldwide is a fundamental driver. More patients with blocked arteries, tumors, or other conditions means a higher volume of interventions (like angioplasties or tumor embolizations) that require these materials. Shift to Minimally Invasive Procedures: Both patients and providers prefer less invasive treatments when available. The success of angioplasty/stenting over open-heart surgery, for example, exemplifies this shift. This drives demand for interventional devices (catheters, stents, guidewires) across cardiology, oncology, orthopedics, and beyond. Technological Innovation: Rapid advancements are improving device performance. Examples include drug-eluting and bioresorbable stents that reduce long-term complications, smart guidewires with better torque control, and catheters with improved coatings for navigation. New materials (like nitinol alloys for flexibility and shape memory) and designs are expanding the capabilities of interventional tools. Improved Imaging and Navigation: Better imaging techniques (high-resolution fluoroscopy, intravascular ultrasound, OCT, etc.) and navigation systems allow more complex procedures to be done interventionally. This in turn expands the scope of what can be treated with catheter-based approaches, indirectly boosting the market for the necessary materials. Growing Healthcare Investment: Many countries are increasing healthcare expenditures. There is a general trend of hospitals upgrading cath labs and interventional suites, especially in developing markets. As infrastructure improves, the volume of procedures (and thus material usage) rises. An expanding middle class in emerging economies is also driving demand for advanced treatments that utilize these devices. Challenges and Restraints High Device Costs: Advanced interventional devices can be expensive (for example, the latest generation drug-eluting stents or robotic catheter systems). In regions with constrained healthcare budgets or in low-resource hospitals, cost can be a barrier to adoption. Some providers may opt for older, cheaper alternatives or limit use to critical cases. Pricing Pressure and Competition: With many players in the market, competition is intense. Hospitals and purchasing groups often negotiate price reductions, which pressures manufacturers' profit margins. Companies must balance affordability with recouping R&D investments. Regulatory and Compliance Hurdles: Developing a new stent or catheter and getting it approved by regulators (like the FDA or CE marking in Europe) is a lengthy process. Strict safety and efficacy requirements are essential for patient safety but can delay time-to-market. Additionally, variations in regulatory standards across countries can complicate global product rollout. Supply Chain Vulnerabilities: The pandemic years highlighted issues in global supply chains for medical components. Shortages of certain plastics or metals, or delays in sterilization services, have impacted device availability at times. Ensuring a robust supply chain and redundancy is now a focus area for companies, but disruptions remain a risk. Clinical Adoption and Training: Some new technologies (e.g. robotic-assisted systems or novel imaging-guided techniques) have a learning curve. If physicians are not trained or comfortable with a new device, they may be slower to adopt it. Training programs and demonstrable improvements in outcomes are needed to convince practitioners to switch from established methods. Browse full Report - Market Segmentation by Product Type Stents – 45% of market share: Stents represent the largest product segment. They are vital in cardiovascular interventions, especially in treating coronary artery disease and peripheral arterial disease by propping open narrowed arteries. Their dominance is due to the high volume of cardiac procedures worldwide. In addition to vascular stents, this category includes stent grafts and other scaffolding implants used in gastroenterology or urology (e.g., bile duct stents, ureteral stents). Balloon Catheters – 25% of market share: Catheters are the second-largest segment, with balloon angioplasty catheters being a major subcategory (often counted separately because of their significance in opening blood vessels during angioplasty). Catheters are versatile tubes used across virtually all interventional procedures to deliver fluids, inflate balloons, deploy stents, or perform ablations. Guidewires – 20% of market share: Guidewires are the thin, flexible wires that physicians first insert and navigate through the anatomy, paving the way for catheters. While they account for a slightly smaller share of revenue relative to stents and catheters, guidewires are indispensable in almost every interventional procedure. They tend to be lower-cost per unit than stents, which partly explains their smaller share of the market value, but in terms of volume, they are used in huge numbers. Table: Global Market Share by Product Type (2024) Product Type Approx. Market Share (2024) Segment Characteristics & Outlook Stents 45% Largest segment driven by high-volume cardiovascular procedures; continual innovation in drug-eluting and bioresorbable stents will sustain growth. Balloon Catheters 25% Key tools for angioplasty and other interventions; new variants like drug-coated balloons boost utility and market demand. Guidewires 20% Ubiquitous support devices for navigation; advancements in materials (e.g. nitinol) improve performance and support steady growth. Others 10% (E.g. sheaths, coils, etc.) A collection of other interventional tools; growing with niche applications but relatively smaller share. Market Segmentation by Application Cardiology – 60% of market share: Cardiology (including interventional cardiology and endovascular procedures for peripheral vascular disease) is the largest application segment for interventional materials. The majority of catheters, guidewires, and stents produced globally are used in cardiovascular procedures. Oncology – 15% of market share: Oncology is an emerging and fast-growing application for interventional materials, often referred to as interventional oncology. This involves minimally invasive procedures to diagnose or treat cancers. Examples include tumor embolization (blocking blood supply to a tumor by injecting embolic agents via catheters), radioembolization (delivering radioactive microspheres through catheters to a tumor site, such as in liver cancer), and ablation procedures (using needle-like probes inserted percutaneously to destroy tumors with extreme heat, cold, or electric fields – some of these probes are guided by catheters or via similar techniques). Orthopedics – 10% of market share: Orthopedic applications of interventional materials are more limited in scope compared to cardiology or oncology, but they represent a growing niche. In orthopedics, 'interventional' procedures often mean minimally invasive treatments of bone or spine conditions. Table: Global Market Share by Application (2024) Application Area Approx. Share (2024) Notes on Usage and Growth Drivers Cardiology 60% Largest segment. Includes coronary and peripheral artery interventions; driven by widespread cardiovascular disease and established efficacy of stents and angioplasty. Oncology 15% Growing segment. Encompasses interventional oncology procedures (tumor embolization, ablation); fueled by rising cancer cases and adoption of minimally invasive tumor therapies. Orthopedics 10% Niche but expanding. Includes spinal interventions (e.g. kyphoplasty) and pain management; growth tied to aging populations and demand for non-surgical orthopedic treatments. Other Applications 15% (GI, Urology, Neuro, etc.) Various other uses of interventional materials; important in their fields (e.g. biliary stents, neurovascular coils) but individually smaller portions of the market. Market Segmentation by End User Hospitals – 60% of demand: Hospitals are the primary end users of interventional materials, accounting for roughly 60% of the market demand. This is because hospitals, especially large acute-care and specialty hospitals, perform the majority of complex interventional procedures. They have dedicated catheterization labs, interventional radiology suites, operating rooms, and the full range of support services (ICUs, emergency care) necessary for high-risk interventions. Ambulatory Surgical Centers (ASCs) – 30% of demand: ASCs are facilities that provide same-day surgical care, including diagnostic and preventive procedures, outside of a hospital setting. Over the last decade, many interventional procedures have started migrating to ASCs because of cost-effectiveness and efficiency. Clinics and Specialty Centers – 10% of demand: This segment includes smaller clinics, physician offices, or specialty centers that perform minimally invasive procedures. Table: Global Market Share by End User (2024) End User Approx. Usage Share (2024) Commentary Hospitals 60% Major tertiary hospitals perform the bulk of complex interventional procedures; they adopt new technologies quickly and drive most of the demand. Ambulatory Surgical Centers (ASCs) 30% ASCs handle many routine or moderate-risk interventions on an outpatient basis; their role is growing as healthcare shifts toward cost-effective same-day procedures. Clinics & Specialty Centers 10% Smaller clinics perform limited types of interventions (e.g. vein treatments, pain management); collectively a smaller share, with gradual growth as office-based labs increase. Market Segmentation by Technology Balloon Angioplasty Techniques: This refers to the classic technology of using balloon catheters to dilate vessels or spaces in the body. Balloon angioplasty is a cornerstone of interventional cardiology and is also used in other fields (like opening a narrowed bile duct or a peripheral artery). In terms of market impact, balloon angioplasty is extremely prevalent – a large proportion of interventional procedures involve a balloon catheter at some stage. Robotic-Assisted Interventions: Robotic-assisted technology in interventional procedures is an exciting and relatively new segment. Robotic catheter navigation systems (such as the CorPath system for vascular procedures or robotic systems for neurovascular and peripheral interventions) allow physicians to perform procedures with robotic precision and even remotely in some cases. Advanced Imaging-Guided Techniques: Imaging is an integral part of all interventional procedures – standard practice uses fluoroscopy (real-time X-ray) for guidance in vascular interventions, and ultrasound or CT for certain others. Here, we highlight the increasing use of advanced imaging techniques and image-guided adjuncts that are transforming interventions. This includes technologies like Intravascular Ultrasound (IVUS) and Optical Coherence Tomography (OCT), where miniaturized imaging probes (often on a catheter or guidewire) are used inside blood vessels to visualize plaques and stent deployment; fusion imaging that combines pre-op CT/MRI with live fluoroscopy for better guidance; and even augmented reality or 3D navigation systems for complex anatomy. Market Segmentation by Distribution Channel Direct Sales – 55% of market sales: In direct sales, medical device companies sell their products straight to hospitals, clinics, or healthcare systems without intermediaries. Over half of the global interventional materials market (by revenue) is supplied via direct sales. Major manufacturers (especially the large ones with global operations) maintain their own sales and distribution networks to serve big clients like hospital systems. Direct sales allow manufacturers to have closer relationships with physicians and hospitals, offer specialized training or support, and handle pricing and contracts directly. Distributors – 30% of market sales: Distributors are intermediary companies that purchase medical products from manufacturers and then supply them to healthcare providers. Roughly 30% of interventional materials reach end users through distributors. This channel is vital for covering geographically broad or hard-to-reach markets and for servicing smaller hospitals and clinics that may not have direct accounts with big manufacturers. Online and Other Channels – 15% of market sales: Though not explicitly listed in the segmentation request, it's worth noting the rise of online procurement platforms and other non-traditional channels, which currently account for roughly 15% of sales. Some hospitals use online marketplaces or centralized procurement systems to order medical supplies (including certain standard catheters or consumables). Table: Distribution Channels for Interventional Materials (Global, 2024) Distribution Channel Share of Sales (2024) Characteristics and Trends Direct Sales 55% Manufacturers selling directly to hospitals/ASCs; offers control over client relationships and often used for major accounts and advanced products. Distributors 30% Intermediaries that supply products to healthcare providers; crucial for broad market coverage and smaller facilities, especially in emerging markets or regions where manufacturers lack direct presence. Online/E-procurement 15% Web-based ordering platforms and group purchasing; growing in use for standard supplies, though high-touch device sales still rely on direct rep support. Buy Now - Key Players and Competitive Landscape Medtronic plc Boston Scientific Corporation Abbott Laboratories Johnson & Johnson (J&J) Terumo Corporation Cook Medical B. Braun Melsungen AG BD (Becton, Dickinson and Company) Philips Healthcare Stryker Corporation W. L. Gore & Associates (Gore Medical) Merit Medical Systems AngioDynamics, Inc. Asahi Intecc Co., Ltd. Recent Developments (2022–2025) Medtronic – October 2023: Product Launch – Medtronic launched a next-generation catheter-based interventional system aimed at enhancing minimally invasive surgeries. This new system integrates advanced imaging capabilities directly into the catheter platform, allowing surgeons to visualize and navigate with greater precision during procedures. The catheter also features improved maneuverability with a more responsive design. Boston Scientific – September 2023: Acquisition – Boston Scientific announced the acquisition of a promising startup specializing in next-generation interventional radiology tools. The startup's portfolio included advanced microcatheters and novel guidewire technology that utilize smart sensors for real-time feedback during procedures. Abbott Laboratories – August 2023: Regulatory Approval – Abbott received U.S. FDA approval for a new interventional device aimed at cardiovascular applications. The device – a novel drug-eluting scaffold (stent) – is notable for its enhanced drug delivery mechanism and a slimmer profile. Clinical trials demonstrated excellent efficacy in keeping arteries open with a favorable safety profile. Johnson & Johnson – June 2023: Strategic Partnership – Johnson & Johnson (through its medical device division) entered into a strategic partnership with a technology company specializing in artificial intelligence (AI) and machine learning for healthcare. The goal of the partnership is to integrate AI-driven analytics into interventional procedures. Concretely, they are working on software that can analyze live imaging feeds and patient data during an intervention to provide decision support – for example, suggesting optimal catheter paths, detecting subtle changes in blood flow, or predicting complications. By combining J&J's medical expertise with the tech company's AI algorithms, the collaboration aims to create smarter interventional systems that help physicians plan and execute procedures with enhanced precision. Stryker Corporation – May 2023: Expansion Initiative – Stryker announced the expansion of one of its manufacturing facilities in India to increase production capacity for interventional treatment materials. This expansion is in response to growing demand in the Asia-Pacific region for interventional products, including Stryker's neurovascular stents and catheters. By scaling up production in India, Stryker aims to serve regional markets more efficiently, reduce costs, and mitigate supply chain risks. Johnson & Johnson – November 2022: Major Acquisition – In late 2022, J&J made headlines by acquiring Abiomed, a company well-known for its Impella heart pump devices, in a multi-billion dollar deal. While Abiomed's products (percutaneous heart pumps) are somewhat adjacent to the classic 'catheter, stent, guidewire' trio, they are used in interventional cardiology for supporting patients with severe heart failure or during high-risk angioplasty. This acquisition by J&J signaled the company's re-entrance into frontline interventional cardiology devices in a big way. Market Recovery Post-Pandemic (2022–2023): After the COVID-19 pandemic disruptions of 2020-2021, the years 2022 and 2023 saw a robust recovery in elective interventional procedure volumes. Hospitals that had postponed non-urgent cardiovascular and other interventions caught up with backlog, which led to a surge in demand for stents, catheters, and related supplies. Companies reported improved sales, especially in the second half of 2022, as cath labs returned to near-full operation. Technology Integration and Minor Players (2024): As we moved into 2024, there's an ongoing wave of integration of digital technology in interventional products. Smaller companies and startups introduced innovations like catheters with built-in sensors that can provide data on pressure or blood flow from within vessels, and guidewires that can act as imaging tools (combining guidance and diagnostics). This report is also available in the following languages : Japanese (介入治療材料市場), Korean (중재 치료 재료 시장), Chinese (介入治疗材料市场), French (Marché des matériaux de traitement interventionnel), German (Markt für interventionelle Behandlungsmaterialien), and Italian (Mercato dei materiali per il trattamento interventistico), etc. Download Full PDF Sample Copy of Market Report @ Related reports - New Medical Dressings Market The global new medical dressings market is valued at an estimated $8.5 billion in 2024, reflecting a steady demand driven by advancements in wound care technologies and an increasing prevalence of chronic wounds. The market is projected to reach approximately $14 billion by 2034, showcasing significant growth opportunities over the next decade. Drug Dispensing Robot Market The global drug dispensing robot market is valued at approximately $3.2 billion in 2024 and is anticipated to reach $7.5 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of around 9.1% during the forecast period from 2025 to 2034. Digital All-In-One Operating Room System Market The global digital all-in-one operating room system market is poised for significant growth, with an estimated market value of $4.5 billion in 2024. This market is projected to reach approximately $10.8 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of 9.1% during the forecast period from 2025 to 2034. Single Use Transfusion Sets Market The global single-use transfusion sets market is valued at approximately $2.5 billion in 2024, with expectations to reach around $4.2 billion by 2034. This growth reflects a robust Compound Annual Growth Rate (CAGR) of 5.4% during the forecast period from 2025 to 2034. Regenerative Dermal Fillers Market The global regenerative dermal fillers market is valued at approximately $6.3 billion in 2024 and is projected to reach around $10.5 billion by 2034, reflecting robust growth opportunities within the sector. This forecast indicates a Compound Annual Growth Rate (CAGR) of about 5.2% from 2025 to 2034. Photonic Medical Equipment Market The global photonic medical equipment market is valued at approximately $15.4 billion in 2024, driven by advancements in laser and imaging technologies that enhance diagnostic and therapeutic capabilities. The market is anticipated to reach around $38 billion by 2034, reflecting significant growth opportunities as the healthcare sector increasingly adopts minimally invasive procedures. This translates to a robust Compound Annual Growth Rate (CAGR) of approximately 9.2% during the forecast period from 2025 to 2034. Freezing Fat Reduction Apparatus Market The global freezing fat reduction apparatus market is projected to reach a value of approximately $800 million in 2024, reflecting a robust demand driven by rising interest in non-invasive body contouring procedures. The market is expected to experience substantial growth, with a forecasted value of around $1.6 billion by 2034, representing a Compound Annual Growth Rate (CAGR) of about 7.5% during the period from 2025 to 2034. Intelligent Blood Collection Management System Market The global Intelligent Blood Collection Management System (IBCMS) market is valued at approximately $2.5 billion in 2024, with projections suggesting a robust growth trajectory that could elevate its value to around $5 billion by 2034. This growth reflects a Compound Annual Growth Rate (CAGR) of approximately 8% during the forecast period from 2025 to 2034. Negative Pressure Diverter Market The global negative pressure diverter market is valued at approximately $3 billion in 2024. As healthcare facilities prioritize infection control and patient safety, the market is poised for robust growth. The projected market value for the period 2025–2034 is estimated to reach around $5 billion, reflecting a Compound Annual Growth Rate (CAGR) of approximately 6.2%. Medical CT Film Market The global medical CT film market is poised for robust growth, valued at approximately $1.2 billion in 2024. This sector is projected to expand at a CAGR of 6.5% from 2025 to 2034, reaching an estimated market value of around $2.3 billion by the end of the forecast period. 3A Sanitary Fixtures for Pharma & Biotech Market The global 3A sanitary fixtures market for the pharmaceutical and biotech sectors is valued at approximately $3.2 billion in 2024, with projections indicating a robust expansion, reaching an estimated $5.6 billion by 2034. This growth reflects a Compound Annual Growth Rate (CAGR) of around 6.2% during the 2025-2034 forecast period. Shielded Isolators and Hot Cells Market The global shielded isolators and hot cells market is valued at approximately $1.2 billion in 2024, with expectations to reach around $2.4 billion by 2034. This growth reflects a robust Compound Annual Growth Rate (CAGR) of 7.4% during the forecast period from 2025 to 2034. Bifidus Product Market The global bifidus product market is estimated to reach approximately $1.3 billion in 2024, driven by increasing health consciousness and the rising demand for probiotic-rich foods. The market is projected to grow at a compound annual growth rate (CAGR) of 8.4%, reaching an estimated value of $2.7 billion by 2034. Molecular Diagnostic Kits Market The global molecular diagnostic kits market is valued at approximately $9.3 billion in 2024, reflecting significant advancements in biotechnology and increasing demand for rapid and accurate diagnostics. The market is projected to reach around $15.6 billion by 2034, driven by heightened adoption of personalized medicine and growing prevalence of infectious diseases. The Compound Annual Growth Rate (CAGR) for the forecast period from 2025 to 2034 is estimated at 6.0%. Medical Reusable Sterilization Container Market The global market for medical reusable sterilization containers is projected to be valued at approximately $1.2 billion in 2024. This market is expected to experience substantial growth, with a projected value of around $2.3 billion by 2034. The Compound Annual Growth Rate (CAGR) for the forecast period from 2025 to 2034 is estimated at 7.1%. Ventilator Humidifiers Market The global ventilator humidifiers market is projected to reach a value of approximately $1.2 billion in 2024, driven by increasing demand for respiratory care across healthcare facilities. The market is expected to grow significantly, with an estimated value of $2.5 billion by 2034, corresponding to a robust Compound Annual Growth Rate (CAGR) of around 8.5% during the forecast period from 2025 to 2034. Prefilled Humidifiers Market the global market for prefilled humidifiers is valued at approximately $2.1 billion, driven by rising consumer demand for healthier indoor air quality and growing awareness of respiratory ailments. The market is projected to expand significantly, with an estimated value of $3.8 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of 6.2% during the forecast period from 2025 to 2034. Prefilled Bubble Humidifiers Market The global prefilled bubble humidifier market is projected to reach a value of approximately $1.2 billion in 2024, driven by an increasing prevalence of respiratory diseases and the growing need for effective humidification in medical settings. The market is expected to experience significant growth, with a projected value of around $2.5 billion by 2034 BPDA Market The global Business Process Digital Automation (BPDA) market is poised for substantial growth, with an estimated value of approximately $6.5 billion in 2024. This momentum is expected to continue, leading to a projected market value of around $15 billion by 2034. This growth corresponds to a robust Compound Annual Growth Rate (CAGR) of approximately 9% over the forecast period from 2025 to 2034. Near Infrared Medical Fluorescence Imaging System Market The global near-infrared (NIR) medical fluorescence imaging system market is valued at approximately $1.3 billion in 2024. It is projected to reach around $3.1 billion by 2034, reflecting significant growth driven by advancements in imaging technology, increasing adoption of NIR imaging in surgical procedures, and the rising prevalence of cancer and other diseases that necessitate precise imaging techniques. The market is expected to grow at a compound annual growth rate (CAGR) of 9% during the forecast period from 2025 to 2034. CONTACT: Contact Data Irfan Tamboli (Head of Sales) Phone: + 1704 266 3234 Email: sales@ in to access your portfolio
Yahoo
19-05-2025
- Automotive
- Yahoo
Vulcanizing Press Market Outlook, Trends, Growth Drivers and Key Challenges
Vulcanizing Press Market Outlook 2025-2034 Luton, Bedfordshire, United Kingdom, May 19, 2025 (GLOBE NEWSWIRE) -- The global vulcanizing press market is set for significant expansion over the forecast period, growing from approximately USD 1.8 billion in 2024 to an estimated USD 3.4 billion by 2034, representing a compound annual growth rate (CAGR) of 6.6%. Vulcanizing presses are essential machinery used in the rubber processing industry to strengthen and shape rubber materials through heat and pressure. These machines play a pivotal role in the production of tires, conveyor belts, rubber sheets, seals, gaskets, and automotive components. Get a Sample PDF Brochure: As industrial automation, sustainable manufacturing practices, and demand for high-performance rubber components increase, vulcanizing presses are evolving from manually operated units to fully automated systems with advanced temperature and pressure control. Key markets include automotive, aerospace, rubber goods manufacturing, and industrial maintenance. Market Dynamics Key Growth Drivers Rising Demand in Automotive and Tire Industries: As the automotive sector grows globally, particularly in developing regions, so does the demand for tires and rubber automotive parts. Vulcanizing presses are essential in tire molding, tread curing, and sealing component production. Boom in Conveyor Belt Manufacturing: Industries such as mining, logistics, food processing, and construction require large volumes of high-quality conveyor belts, which depend on vulcanizing presses for durability and seamless joints. Focus on Quality and Efficiency: Manufacturers are replacing outdated manual systems with semi-automatic or fully automatic presses that offer superior cycle times, digital control, and improved safety standards. Innovation in Rubber Materials: New synthetic elastomers and composites require precision curing processes, driving investment in advanced vulcanizing technologies. Growth in Aerospace and Defense Applications: Lightweight, heat-resistant rubber parts for aircraft and defense machinery are gaining relevance, requiring specialized high-temperature vulcanization solutions. Restraints High Initial Investment: Automated and hydraulic presses with modern features come at a premium, creating capital barriers for small and medium manufacturers. Operational Complexity: High-precision vulcanizing requires trained technicians and adherence to strict process protocols, which may pose implementation challenges. Environmental Concerns: The use of heat, pressure, and sometimes chemical additives in vulcanization can have environmental implications, pushing regulatory scrutiny. Opportunities Emerging Markets in Asia and Africa: Infrastructure development, increasing tire production, and industrialization are opening up new markets for vulcanizing press manufacturers. Customization and Modular Press Designs: Offering scalable solutions for various product sizes and curing requirements can help manufacturers serve diverse industry needs. Integration with Smart Manufacturing Platforms: IoT-enabled presses with remote diagnostics, predictive maintenance, and energy consumption tracking are future-ready. Market Segmentation By Product Type Hydraulic Vulcanizing Press: Dominant in the market due to their high clamping force and adaptability for large rubber components. These presses are suitable for tire, conveyor belt, and industrial part manufacturing. Pneumatic Vulcanizing Press: Utilized for medium-pressure applications, these presses offer quicker actuation and are popular in small-to-medium rubber product manufacturing. Mechanical Vulcanizing Press: Traditional, gear-driven systems still in use for basic applications due to their low cost and rugged construction, though being phased out in favor of more precise options. By Application Rubber Industry: The primary sector for vulcanizing presses, with applications ranging from footwear and hoses to seals and mats. Quality control and curing uniformity are critical. Automotive Industry: Produces molded components like gaskets, door seals, engine mounts, and suspension parts. OEM suppliers rely on customized vulcanizing cycles for complex geometries. Aerospace Industry: Demands specialized materials such as silicone rubber and fluoroelastomers, cured under controlled environments for aircraft interiors, seals, and insulation. By End User Manufacturers: Rubber component and product manufacturers represent the largest consumer segment. They utilize presses for mass production and prototyping. Repair Shops: Used in tire and conveyor belt repair for splicing, patching, and reshaping. Portable vulcanizing presses are increasingly adopted. Research Institutions: Applied in material testing, prototype development, and academic research on elastomers and composites. By Technology Manual Vulcanizing Press: Basic models used in small-scale operations or educational labs. Limited in automation and precision. Semi-Automatic Vulcanizing Press: Offers better control of curing parameters with partial automation, often used in mid-sized production lines. Fully Automatic Vulcanizing Press: Equipped with PLC systems, auto temperature calibration, mold recognition, and remote operation features. Preferred in high-volume, high-precision applications. By Distribution Channel Online Sales: Growing among small-to-medium businesses and repair shops, especially for modular and portable presses. E-commerce platforms and manufacturer websites support direct procurement. Offline Sales: Traditional distribution remains strong for capital equipment. Includes dealers, industrial equipment showrooms, and direct sales through B2B channels. Browse full Report - Regional Insights North America: A mature market led by the U.S., with significant demand from the automotive, aerospace, and defense sectors. Emphasis on energy efficiency and safety compliance fosters modernization. Europe: Germany, France, and Italy lead with strong rubber machinery exports and advanced manufacturing standards. Sustainability directives are pushing greener vulcanization processes. Asia-Pacific: The fastest-growing region due to China, India, and Southeast Asia's growing manufacturing footprint. Domestic demand and export-driven tire production are major contributors. Latin America: Emerging industrial sectors in Brazil and Mexico support steady demand for tire repair and conveyor vulcanization equipment. Middle East & Africa: Industrialization and resource-driven industries (oil, mining) create demand for conveyor belt production and maintenance, driving equipment purchases. Competitive Landscape The market is characterized by a mix of established multinational firms and local machine tool manufacturers offering region-specific solutions. Key Companies Include: HF Group: A global leader in tire curing presses with advanced automation. DESMA: Specializes in injection molding and vulcanization technologies for technical rubber goods. Barwell Global: Known for preformers and rubber processing systems. Yiyuan Machinery: A prominent player in China focusing on custom hydraulic and conveyor belt vulcanizing presses. Gurki Industrial: Offers a range of semi-automatic and automatic vulcanizing systems for export markets. Buy Now : Strategic Developments: R&D investments in energy-efficient heating systems (induction, infrared). Integration with cloud-based production monitoring platforms. Strategic partnerships with tire manufacturers for tailored press designs. Emerging Trends Eco-Vulcanization Techniques: Use of low-emission heaters and non-toxic vulcanizing agents to meet sustainability benchmarks. Smart Vulcanizing Presses: Incorporation of sensors, data logging, and AI-driven fault detection for predictive maintenance. Modular Press Architecture: Easily reconfigurable press systems for varying product sizes and faster mold changes. 3D Mold Simulation Integration: Using CAD-based simulations to optimize pressure, heat distribution, and cycle timing before production. This report is also available in the following languages : Japanese (加硫プレス市場), Korean (가황 프레스 시장), Chinese (硫化机市场), French (Marché des presses de vulcanisation), German (Markt für Vulkanisierpressen), and Italian (Mercato delle presse vulcanizzanti), etc. Download Full PDF Sample Copy of Market Report @ Related Reports Bituminous Expansion Joint Market The global market for bituminous expansion joints is valued at approximately $1.2 billion in 2024, with an expected market growth to around $1.9 billion by 2034. This growth represents a Compound Annual Growth Rate (CAGR) of about 4.7% during the forecast period of 2025 to 2034. Diamond Impregnated Bit Market The global diamond impregnated bit market is valued at approximately $1.2 billion. The market is anticipated to reach $2.4 billion by 2034, indicating a robust growth trajectory driven by increasing demand in drilling applications across various sectors, including oil and gas, mining, and construction. The projected Compound Annual Growth Rate (CAGR) for the period 2025–2034 is estimated at 7.5%, reflecting sustained investment in drilling technologies and the rise of efficient resource extraction methods. Lightweight Roof System Market The global lightweight roof system market is valued at approximately $22 billion in 2024, with projections indicating growth to nearly $38 billion by 2034. This growth corresponds to a Compound Annual Growth Rate (CAGR) of about 5.6% during the forecast period from 2025 to 2034. Lightweight Concrete Wall Panel Market The global lightweight concrete wall panel market is valued at approximately $4.2 billion in 2024, with projections indicating a significant increase to around $7.3 billion by 2034. This represents a robust CAGR of about 6.1% during the forecast period from 2025 to 2034. Exposed Aggregate Concrete Market The global exposed aggregate concrete market is poised for significant growth, with a projected market value of approximately $12 billion in 2024. The segment is expected to reach around $18 billion by 2034, reflecting a Compound Annual Growth Rate (CAGR) of about 5.5% during the forecast period from 2025 to 2034. Glass Aggregate Concrete Market The global glass aggregate concrete market is valued at approximately $5 billion in 2024, with expectations to reach around $9.8 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of 7.2% during the forecast period from 2025 to 2034. Macro 3D Printing Market The global 3D printing market is estimated to reach a value of approximately $30 billion in 2024, driven by increased adoption across diverse industries such as healthcare, aerospace, and automotive. The market is projected to expand significantly, with an expected value of around $70 billion by 2034, reflecting a Compound Annual Growth Rate (CAGR) of roughly 9% during the forecast period from 2025 to 2034. Robotic Arm 3D Printer Market The global robotic arm 3D printer market is poised for significant advancement, valued at approximately $1.2 billion in 2024. This vibrant sector is projected to reach around $3.6 billion by 2034, driven by increased adoption across industries such as manufacturing, aerospace, and healthcare. This growth translates to a robust Compound Annual Growth Rate (CAGR) of approximately 12% during the forecast period from 2025 to 2034. Electroplated Diamond Wire Saw Market The global electroplated diamond wire saw market is valued at approximately $330 million in 2024, with projections indicating robust growth, reaching an estimated $600 million by 2034. This represents a Compound Annual Growth Rate (CAGR) of around 6.3% during the forecast period from 2025 to 2034. Coating Defect Detection System Market The global coating defect detection system market is projected to reach approximately $1.2 billion in 2024, reflecting robust growth driven by increasing quality standards across various industries, including automotive and aerospace. By 2034, the market is estimated to grow to around $2.5 billion, indicating a significant opportunity for innovation and investment. This growth corresponds to a Compound Annual Growth Rate (CAGR) of approximately 7.5% over the forecast period from 2025 to 2034. Measuring and Inspection Systems for Plastic Market The global market for measuring and inspection systems for plastics is valued at approximately $4.2 billion in 2024, with projections anticipating growth to around $6.5 billion by 2034. This reflects a Compound Annual Growth Rate (CAGR) of about 4.5% during the forecast period from 2025 to 2034. Troughed Belt Conveyor Market The global troughed belt conveyor market is valued at approximately $7.5 billion in 2024, with projections indicating a market value of around $12 billion by 2034. This growth reflects a Compound Annual Growth Rate (CAGR) of 5.1% during the forecast period of 2025 to 2034. Telescopic Belt Conveyor Market The global telescopic belt conveyor market is poised for robust growth, with an estimated market value of approximately $1.5 billion in 2024. Projections indicate a rise to around $2.9 billion by 2034, reflecting a compound annual growth rate (CAGR) of 7.3% during the forecast period from 2025 to 2034. Loading Rack Market The global loading rack market is projected to reach a value of approximately $3.2 billion in 2024, with an anticipated growth trajectory leading to about $5.6 billion by 2034. This growth represents a CAGR of 6.5% during the forecast period from 2025 to 2034. Swing Arm Sorter Market The global swing arm sorter market is valued at approximately $1.1 billion in 2024, with forecasts suggesting it will expand to around $1.9 billion by 2034, driven by the increasing demand for automated material handling systems. This growth translates to a robust Compound Annual Growth Rate (CAGR) of 6.4% during the forecast period from 2025 to 2034. Modular Piping System Market The global modular piping system market is valued at approximately $8.5 billion in 2024, with forecasts indicating growth to around $14 billion by 2034. This represents a Compound Annual Growth Rate (CAGR) of about 6.1% during the forecast period from 2025 to 2034. Modular Gangway Market The global modular gangway market is estimated to reach a value of approximately $1.2 billion in 2024, driven by increased demand from the maritime and offshore oil & gas sectors for flexible docking solutions. Projected growth during the forecast period from 2025 to 2034 indicates a market value of around $2.3 billion, reflecting a robust Compound Annual Growth Rate (CAGR) of approximately 7.2%. Dimension Weighing and Scanning (DWS) System Market The global Dimension Weighing and Scanning (DWS) system market is projected to reach a value of approximately $850 million in 2024, with an anticipated growth trajectory forecasting a market value of $1.5 billion by 2034. This signifies a Compound Annual Growth Rate (CAGR) of around 6.2% during the period from 2025 to 2034. Skewed Wheel Diverter Market The global market for skewed wheel diverters is valued at approximately $450 million in 2024, with projections estimating a growth to around $620 million by 2034. This growth trajectory reflects a compound annual growth rate (CAGR) of 3.5% during the forecast period of 2025 to 2034. Rideable Material Lift (RML) Market The global Rideable Material Lift (RML) market is valued at approximately $2.5 billion in 2024 and is projected to reach around $4.1 billion by 2034. This growth represents a robust Compound Annual Growth Rate (CAGR) of about 5.1% during the forecast period from 2025 to 2034. CONTACT: Contact Data Irfan Tamboli (Head of Sales) Phone: + 1704 266 3234 Email: sales@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
15-05-2025
- Business
- Yahoo
Biofumigation Market Analysis,Trends, Innovations, and Growth Outlook
Biofumigation Market Overview And Outlook 2025-2034 Luton, Bedfordshire, United Kingdom, May 15, 2025 (GLOBE NEWSWIRE) -- The global biofumigation market is gaining significant momentum as agriculture transitions toward more sustainable and eco-friendly practices. Valued at approximately USD 1.2 billion in 2024, the market is projected to reach nearly USD 2.5 billion by 2034, growing at a robust CAGR of 7.5% over the forecast period (2025–2034). This growth is primarily driven by the rising global demand for sustainable crop protection, increased regulatory scrutiny around synthetic chemicals, and the growing awareness among farmers and consumers about the environmental impact of conventional fumigation practices. Get a Sample PDF Brochure: Shifting Focus Toward Eco-Friendly Solutions Biofumigation involves the use of glucosinolate-rich plants, particularly from the Brassicaceae family, as a natural alternative to chemical fumigants. These plants are either grown as cover crops and later incorporated into the soil, or their seed meals and oils are used to release isothiocyanates, naturally occurring compounds known for their pest-suppressing and soil-enriching properties. This practice has shown promising results in suppressing soil-borne pathogens, nematodes, weeds, and harmful fungi, while simultaneously improving soil health. Unlike chemical fumigants, biofumigants also help reduce environmental toxicity and enhance soil structure, making them a favored choice among both organic and conventional farmers looking to boost long-term productivity. Key Growth Drivers Sustainable Agriculture Movement: As agriculture faces increasing pressure to become more environmentally conscious, biofumigation is emerging as a powerful solution that aligns with modern regenerative farming goals. Regulatory Push for Chemical Alternatives: Governments and agricultural agencies worldwide are encouraging reduced dependence on synthetic fumigants by supporting bio-based crop protection methods, which further fuels market adoption. R&D and Product Innovation: Leading players in the biofumigation space are actively investing in the development of high-performance seed meals, oils, and green manure products that deliver consistent results in diverse climates and soil types. Worker and Consumer Safety: Biofumigants significantly reduce exposure to hazardous chemicals, offering safer alternatives for farm workers and helping producers meet rising consumer expectations for cleaner, more responsibly grown food. A Versatile Tool for Modern Farming Biofumigation is now widely recognized as a valuable tool in integrated pest management (IPM) strategies across various crops. It offers numerous benefits beyond pest suppression, including: Enhancing soil permeability and structure Increasing organic carbon and microbial activity Supporting higher yields in both organic and conventional systems This multi-functional approach makes biofumigation a cost-effective, scalable, and environmentally conscious solution for farms of all sizes. Browse full Report - Key Market Drivers 1. Surge in Organic Farming Practices With consumers increasingly opting for chemical-free food, organic farming is on the rise. Biofumigation—an eco-friendly technique using natural compounds from plants like mustard and brassicas—is proving to be a reliable alternative for soil-borne pest and disease control. This method fits well within organic farming standards, helping farmers boost productivity while preserving soil health and biodiversity. 2. Regulatory Pressure on Chemical Pesticides As global regulations tighten on the use of synthetic pesticides, biofumigants are gaining favor. Governments and regulatory bodies are encouraging the use of natural fumigants, which are not only safer for workers and consumers but also environmentally sustainable. This shift is accelerating the adoption of biofumigation across developed and emerging agricultural economies. 3. Growing Focus on Soil Health and Long-Term Sustainability Modern agriculture is increasingly prioritizing soil health as a foundation for resilient farming. Biofumigants, when incorporated into the soil, enhance microbial diversity, improve organic matter, and help suppress harmful pathogens. This long-term benefit is fostering strong interest among progressive farmers and agribusinesses alike. Key Players in the Biofumigation Landscape Some of the prominent companies leading innovation and development in this space include: BASF SE UPL Group Isagro USA, Inc. Marrone Bio Innovations, Inc. Senova P.H. Petersen Eastman Chemical Company Mighty Mustard Tozer Seeds Harley Seeds, among others. These players are focusing on product innovation, including the development of new biofumigant seed species, seed meals, and oil-based formulations, tailored to meet the rising demand for natural crop protection. Buy Now : Market Insights by Application Biofumigation serves multiple functions across various farming systems: Soil Health Improvement – Accounted for USD 0.75 billion in 2023, driven by the demand for enriched soil quality and organic matter. Pest Control – Valued at USD 0.65 billion, offering an effective tool for suppressing harmful insects and pests. Nematode Management – Represented USD 0.45 billion, targeting root-knot and soil nematodes. Disease Management – Held USD 0.4 billion, addressing soil-borne fungal and bacterial pathogens. This broad spectrum of benefits underscores biofumigation's growing relevance in modern sustainable agriculture. Mustard: A High-Demand Ingredient Among active ingredients, mustard seed stands out for its high concentration of glucosinolates, which convert into potent pest-suppressing compounds. Its use in seed meals and oils is increasing rapidly due to effectiveness in managing weeds, nematodes, and soil-borne diseases, particularly in high-value crops such as strawberries and raspberries. Market Insights by Method Soil Incorporation: Direct mixing of green manure into the soil for effective microbial activation. Cover Cropping: Often used in rotation to naturally suppress pests while improving soil fertility. Composting: A growing method for waste recycling and natural pathogen suppression. Each technique plays a pivotal role in enhancing soil vitality and reducing chemical dependency. End-Use Sectors Driving Adoption Agriculture: The core user segment, driven by the need for eco-friendly pest control. Horticulture: Rapid growth due to demand for clean produce and ornamental plant care. Landscaping: Increasing use of biofumigants in urban environments to support green initiatives. Regional Insights Asia Pacific Poised for significant growth due to rising pest outbreaks, increased awareness of sustainable practices, and strong government backing for environmentally safe farming inputs. Countries like India, China, and Australia are spearheading the regional momentum. North America Maintains a strong market presence thanks to advanced organic farming infrastructure, favorable regulatory environments, and a solid base of leading biofumigation companies such as Marrone Bio Innovations and Eastman Chemical Company. Challenges & Opportunities While the biofumigation market faces challenges such as limited awareness, higher product costs, and regulatory complexities, the long-term benefits outweigh the hurdles. Continuous investment in R&D, coupled with farmer education initiatives, is expected to close these gaps and foster stronger adoption. Key Competitors : 1. BASF SE 2. Bayer AG 3. Corteva Agriscience 4. Syngenta AG 5. FMC Corporation 6. UPL Limited 7. Certis USA 8. BioWorks, Inc. 9. Marrone Bio Innovations 10. Valent BioSciences LLC 11. Terra Genesis International 12. AgraQuest (now part of Bayer) 13. EcoSMART Technologies, Inc. 14. Green Solutions 15. Meiji Seika Pharma Co., Ltd. 16. W. Neudorff GmbH KG 17. Amyris, Inc. 18. BioSafe Systems, LLC 19. AgTech Scientific 20. FytoFend Recent Industry Developments in the Biofumigation Market 1. BASF SE – January 2023 Product Innovation for Soil Health BASF launched a novel biopesticide aimed at enhancing both soil and plant health through biofumigation. This innovative product underscores BASF's commitment to sustainable agriculture and positions the company at the forefront of eco-friendly crop protection solutions. 2. Bayer AG – March 2023 Strategic Partnership to Empower Smallholder Farmers Bayer announced a collaborative initiative with TechnoServe to promote sustainable agricultural practices, including biofumigation, across smallholder farms in Africa. This strategic move aims to improve soil health, boost productivity, and enhance the livelihoods of local farming communities through science-backed solutions. 3. Corteva Agriscience – April 2023 Acquisition to Strengthen Biofumigant Capabilities Corteva expanded its presence in the biofumigation sector by acquiring a biotechnology firm specializing in biofumigant crop varieties. This acquisition aligns with Corteva's broader strategy of delivering innovative, natural solutions to support resilient and productive farming systems. 4. Syngenta AG – May 2023 Launch of Integrated Biofumigation Solutions Syngenta introduced a comprehensive package of biofumigation solutions that integrates digital agriculture tools for enhanced application precision and field performance. This launch reflects Syngenta's focus on leveraging data-driven agriculture to maximize the impact of sustainable pest and disease management practices. 5. FMC Corporation – June 2023 Investing in Next-Generation Bio-Based Products FMC made a strategic investment in the development of bio-based pest control solutions, aiming to significantly improve the effectiveness and scalability of biofumigation. This move reinforces the company's commitment to advancing environmentally responsible crop protection technologies. 6. UPL Limited – July 2023 Joint Venture to Expand Market Reach in Asia-Pacific UPL formed a joint venture with a regional agritech firm to introduce and scale biofumigation practices across key Asia-Pacific markets. This partnership is focused on offering growers effective, eco-friendly alternatives to chemical fumigants, while enhancing regional food security and environmental stewardship. Biofumigation Market Segment Analysis By Type of Biofumigants - Mustard and Other Brassicas - Non-Brassica Crops - Biocontrol Agents By Application - Agricultural Crop Protection - Soil Health Improvement - Pest and Nematode Control By Formulation - Solid Formulations - Liquid Formulations - Granular Formulations By End-use - Fruits and Vegetables - Field Crops - Turfs and Ornamental Plants By Distribution Channel - Direct Sales - Distributors/Wholesalers - Online Sales By Region - North America - Europe - Asia-Pacific - Latin America - Middle East and Africa This report is also available in the following languages : Japanese (バイオ燻蒸市場), Korean (생물 훈증 시장), Chinese (生物熏蒸市场), French (Marché de la biofumigation), German (Markt für Biofumigation), and Italian (Mercato della biofumigazione), etc. Get a Sample PDF Brochure: More Research Finding – United States Green Polyol & Bio Polyol Market The United States green polyol and bio polyol market is poised to reach a value of approximately $1.2 billion in 2024, driven by increasing demand for sustainable materials in various applications, particularly in the foam and coatings industries. From 2025 to 2034, the market is projected to expand at a compound annual growth rate (CAGR) of 10.5%. Packaged Fruit Juice Market Packaged Fruit Juice market is valued at approximately $172 billion and is projected to reach about $245 billion by 2034. This growth represents a Compound Annual Growth Rate (CAGR) of 4.5% during the forecast period from 2025 to 2034. Gypsum Agriculture Market The global gypsum agriculture market is valued at approximately $1.5 billion in 2024, with a projected growth to around $2.5 billion by 2034. This translates to a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period from 2025 to 2034. Agriculture Inputs Testing Market The global Agricultural Inputs Testing Market is estimated to be valued at approximately $12 billion in 2024, with projections indicating it will grow to around $20 billion by 2034. This reflects a Compound Annual Growth Rate (CAGR) of about 6.0% during the forecast period from 2025 to 2034. Food Basket Market The global Food Basket market is valued at approximately $200 billion in 2024, with projections indicating robust growth to reach around $300 billion by 2034. This represents a Compound Annual Growth Rate (CAGR) of 4.5% during the forecast period from 2025 to 2034. Delivery And Takeaway Food Market Delivery and takeaway food market is valued at approximately $150 billion and is projected to reach around $300 billion by 2034. This growth translates to a robust Compound Annual Growth Rate (CAGR) of about 7.5% during the forecast period from 2025 to 2034. Paddy Rice Market The global Paddy Rice market is valued at approximately $450 billion in 2024, with expectations to reach around $600 billion by 2034, reflecting a significant growth trajectory. This indicates a compound annual growth rate (CAGR) of around 3.1% during the forecast period from 2025 to 2034. CBD Beverage Market The CBD Beverage market is projected to reach an estimated value of $3.6 billion in 2024, driven by increasing consumer interest in wellness products and the shifting perception of hemp-derived CBD. Analysts forecast a robust growth trajectory, predicting market value to expand to approximately $12 billion by 2034, resulting in a Compound Annual Growth Rate (CAGR) of around 13% during the 2025–2034 period. Brewer's Yeast Supplement Market The Brewer's Yeast Supplement market is anticipated to reach a value of approximately $500 million in 2024, driven by increasing health awareness and a surge in demand for natural dietary supplements. As consumers gravitate towards holistic health solutions, the market is projected to grow at a compound annual growth rate (CAGR) of 7.5% from 2025 to 2034. Flavored Snack Pellet Market The global Flavored Snack Pellet market is projected to reach a value of approximately $3.8 billion in 2024, driven by increasing consumer demand for convenient and flavorful snacks. Forecasted growth will see the market expanding to around $6.5 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of 5.5% during the period from 2025 to 2034. A2 Dairy Product Market The A2 Dairy Product market is projected to reach approximately $4.5 billion in 2024, driven by increasing consumer awareness of health benefits associated with A2 proteins. Forecasts suggest robust growth, positioning the market value to reach an estimated $8 billion by 2034. This indicates a Compound Annual Growth Rate (CAGR) of about 6.5% from 2025 to 2034. Vegan Salad Dressing Market The global Vegan Salad Dressing market is valued at approximately $1.2 billion in 2024, with projections suggesting it may reach around $2.5 billion by 2034. This indicates a strong growth trajectory, supported by an estimated Compound Annual Growth Rate (CAGR) of 8.0% during the forecast period from 2025 to 2034. Vitamin Yeast Market The global Vitamin Yeast Market is poised to reach an estimated value of $1.2 billion in 2024, driven by rising consumer demand for fortified food products and nutritional supplements. The market is anticipated to grow significantly, with a projected value of $2.4 billion by 2034, reflecting robust expansion within health-conscious demographics. Wheat Malt Market Wheat Malt Market is valued at approximately $3.5 billion and is poised for significant growth over the next decade. Forecasts suggest that the market will reach around $5.8 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of 5.2% during the 2025-2034 period. Vegetarian Taco Market The Vegetarian Taco market is poised for substantial growth, currently valued at approximately $2 billion in 2024. As the popularity of plant-based diets rises, the market is projected to reach around $4.5 billion by 2034. This growth indicates a robust Compound Annual Growth Rate (CAGR) of about 8.5% during the forecast period from 2025 to 2034. Flavored Butter And Oil Market The Flavored Butter And Oil market is expected to reach a substantial value of approximately $3.2 billion in 2024. The growth trajectory is promising, with projections indicating a market value of around $5.6 billion by 2034. This suggests a Compound Annual Growth Rate (CAGR) of about 6.1% during the forecast period from 2025 to 2034. Flavouring Agent Market The global flavoring agents market is valued at approximately $28.5 billion in 2024, driven by the rising demand for natural and organic flavors in food and beverage applications. The market is projected to grow significantly, reaching an estimated $42 billion by 2034, reflecting a robust CAGR of around 4.5% during the forecast period (2025–2034). Flavored Plant-Based Yogurt Market The global flavored plant-based yogurt market is poised for substantial growth, with an estimated market value of approximately $3.5 billion in 2024. Projections indicate this segment could reach about $7.1 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of around 7.8% during the forecast period from 2025 to 2034. Vegan Sauce Market The Vegan Sauce market is valued at approximately $1.2 billion in 2024, with projections suggesting it will reach around $2.5 billion by 2034. This represents a Compound Annual Growth Rate (CAGR) of about 8.1% during the forecast period of 2025 to 2034. Packaged Honey Market The global Packaged Honey market is valued at approximately $12.5 billion in 2024, with projections indicating a robust growth trajectory that anticipates reaching around $21 billion by 2034. This reflects a compound annual growth rate (CAGR) of about 6.1% during the forecast period from 2025 to 2034. CONTACT: Contact Data Irfan Tamboli (Head of Sales) Phone: + 1704 266 3234 Email: sales@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
